Halozyme Therapeutics
HALO
#2002
Rank
A$11.99 B
Marketcap
$94.69
Share price
1.33%
Change (1 day)
55.24%
Change (1 year)

Halozyme Therapeutics (HALO) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$2.51 B

According to Halozyme Therapeutics's latest financial reports the company's total liabilities are A$2.51 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Halozyme Therapeutics - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$2.42 B-1.45%
2022-12-31A$2.45 B96.83%
2021-12-31A$1.24 B124.24%
2020-12-31A$0.55 B-17.48%
2019-12-31A$0.67 B148.38%
2018-12-31A$0.27 B-31.96%
2017-12-31A$0.39 B-2.15%
2016-12-31A$0.40 B114.06%
2015-12-31A$0.19 B25.37%
2014-12-31A$0.15 B11.31%
2013-12-31A$0.13 B64.85%
2012-12-31A$82.82 M54.81%
2011-12-31A$53.5 M-23.7%
2010-12-31A$70.12 M-10.72%
2009-12-31A$78.54 M-11.34%
2008-12-31A$88.58 M69.41%
2007-12-31A$52.29 M79.15%
2006-12-31A$29.18 M827.25%
2005-12-31A$3.14 M54.24%
2004-12-31A$2.04 M454.81%
2003-12-31A$0.36 M-66.03%
2002-12-31A$1.08 M16704.16%
2001-12-31A$0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$1.00 B-60.14%๐Ÿ‡บ๐Ÿ‡ธ USA
A$87.35 B 3,366.56%๐Ÿ‡บ๐Ÿ‡ธ USA
A$27.90 B 1,007.36%๐Ÿ‡บ๐Ÿ‡ธ USA
A$192.31 B 7,531.89%๐Ÿ‡บ๐Ÿ‡ธ USA
A$91.25 B 3,521.58%๐Ÿ‡ซ๐Ÿ‡ท France
A$164.31 B 6,420.72%๐Ÿ‡บ๐Ÿ‡ธ USA